Molecular docking study and development of an empirical binding free energy model for phosphodiesterase 4 inhibitors
Authors:
- Carlos M.R. Sant’aNnaCSCarlos M.R. Sant’aNna
- Ernesto R. CaffarenaECErnesto R. Caffarena
- Laurent E. DardenneLDLaurent E. Dardenne
- Eliezer J. BarreiroEBEliezer J. Barreiro
- 1 September 2006
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 14 (17) , 6001-6011
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Three-Dimensional Structures of PDE4D in Complex with Roliprams and Implication on Inhibitor SelectivityStructure, 2003
- The Molecular Biology of Cyclic Nucleotide Phosphodiesterases1999
- Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma AgentsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- The Multienzyme PDE4 Cyclic Adenosine Monophosphate–Specific Phosphodiesterase Family: Intracellular Targeting, Regulation, and Selective Inhibition by Compounds Exerting Anti-inflammatory and Antidepressant Actions1998
- Human Recombinant Phosphodiesterase 4B2B Binds (R)-Rolipram at a Single Site with Two AffinitiesBiochemistry, 1997
- Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cellsBiochemical Journal, 1997
- Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein KinaseJournal of Biological Chemistry, 1996
- Animal Trial Prediction and Clinical Effect of New Chemical Substances to be Used as Antipsychotic AgentsPharmacopsychiatry, 1985
- Results of a Phase II Study of the Antidepressant Effect of RolipramPharmacopsychiatry, 1984
- Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitorsNeuropharmacology, 1983